In recent trading session, Exact Sciences Corp (NASDAQ:EXAS) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.96. Company’s recent per share price level of $54.77 trading at $2.96 or 5.71% at last check today assigns it a market valuation of $10.33B. That most recent trading price of EXAS’s stock is at a discount of -32.97% from its 52-week high price of $72.83 and is indicating a premium of 27.02% from its 52-week low price of $39.97. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.61 million shares which gives us an average trading volume of 2.94 million if we extend that period to 3-months.
For Exact Sciences Corp (EXAS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.43. Splitting up the data highlights that, out of 16 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Exact Sciences Corp (NASDAQ:EXAS) trade information
Upright in the green today for gaining 5.71%, in the last five days EXAS remained trading in the green while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $54.77 price level, subtracting -2.95% to its value on the day. Exact Sciences Corp’s shares saw a change of 32.39% in year-to-date performance and have moved 3.30% in past 5-day. Exact Sciences Corp (NASDAQ:EXAS) showed a performance of -5.70% in past 30-days. Number of shares sold short was 7.93 million shares which calculate 2.58 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 65 to the stock, which implies a rise of 15.74% to its recent value today. Analysts have been projecting 60 as a low price target for the stock while placing it at a high target of 70. It follows that stock’s current price would drop -9.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -9.55% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -54.24% during past 5 years.
Exact Sciences Corp (NASDAQ:EXAS)’s Major holders
Insiders are in possession of 0.92% of company’s total shares while institution are holding 98.51 percent of that, with stock having share float percentage of 99.42%. Investors also watch the number of corporate investors in a company very closely, which is 98.51% institutions for Exact Sciences Corp that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at EXAS for having 18.18 million shares of worth $767.91 million. And as of 2024-06-30, it was holding 9.8611 of the company’s outstanding shares.
The second largest institutional holder is CAPITAL WORLD INVESTORS, which was holding about 16.5 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.9529 of outstanding shares, having a total worth of $697.18 million.
On the other hand, GROWTH FUND OF AMERICA and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 9.63 shares of worth $520.98 million or 5.11% of the total outstanding shares. The later fund manager was in possession of 5.88 shares on Mar 31, 2025 , making its stake of worth around $317.9 million in the company or a holder of 3.12% of company’s stock.
